<DOC>
	<DOCNO>NCT00181844</DOCNO>
	<brief_summary>The main objective study ass effectiveness safety lamotrigine treatment youth bipolar bipolar spectrum disorder . This exploratory , 12-week , open-label treatment period , pilot study , youth age 6-17 , meet DSM-IV diagnostic criterion bipolar I , bipolar II , bipolar spectrum disorder . The study result use generate hypothesis large randomize control clinical trial . Based available literature adult bipolar disorder , hypothesize lamotrigine efficacious well tolerate youth pediatric bipolar bipolar spectrum disorder .</brief_summary>
	<brief_title>Lamotrigine Treatment Mania Youth Ages 6-17 With Bipolar Disorder</brief_title>
	<detailed_description>Lamotrigine new generation antiepileptic drug , approve FDA 2003 maintenance treatment adult Bipolar I disorder delay time occurrence mood episode ( depression , mania , hypomania , &amp; mixed episode ) patient treat acute mood episode standard therapy . Recent study show Lamotrigine maintenance treatment robust bipolar depression . The study include 1 ) use 12-week design document response rate 2 ) assessment impact Lamotrigine functional capacity cognition , 3 ) careful assessment safety tolerability .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>1 . Male female subject , 617 year age . 2 . Subjects must DSMIV diagnosis bipolar I , bipolar II disorder bipolar spectrum disorder currently display manic , hypomanic , mixed symptom ( without psychotic feature ) accord DSMIV base clinical assessment confirm structured diagnostic interview ( Kiddie Schedule Affective Disorders Schizophrenia Epidemiological Version . Bipolar Spectrum Disorder ( subthreshold bipolar disorder ) operationalized severe mood disturbance , meet DSMIV Criteria A bipolar disorder meet few element criterion B ( require 2 item elation category 3 irritability ) . 3 . Subjects legal representative must level understanding sufficient communicate intelligently investigator study coordinator , cooperate test examination require protocol . 4 . Subjects legal representative must consider reliable . 5 . Each subject his/her authorized legal representative must understand nature study . The subject 's authorized legal representative must sign informed consent document subject must sign informed assent document . 6 . Subjects must initial score YMRS total score least 20 . 7 . Subject must able participate mandatory blood draw . 8 . Subject must able swallow pill . 9 . Subjects comorbid ADHD , ODD , CD , anxiety depressive disorder allow participate study provide meet exclusionary criterion . 10 . For concomitant stimulant therapy use treat ADHD , subject must stable dose medication 1 month prior study enrollment . The dose stimulant therapy change throughout duration study . 1 . Investigator his/her immediate family ; define investigator 's spouse , parent , child , grandparent , grandchild . 2 . Subjects unable swallow pill . 3 . Serious , unstable illness include hepatic , renal , gastroenterological , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic , hematologic disease . 4 . History sensitivity lamotrigine know , severe allergy multiple adverse drug reaction . 5 . History previous bone marrow depression . 6 . History serious rash . 7 . DSMIV substance ( except nicotine caffeine ) dependence within past 3 month . 8 . Judged clinically serious suicidal risk . 9 . Any concomitant medication primarily central nervous system activity specify Concomitant Medication portion protocol . 10 . A nonresponder history intolerance lamotrigine adequate trial ( 2 month adequate dose ) determine clinician . 11 . Current diagnosis schizophrenia . 12 . Pregnant nursing female .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>bipolar disorder</keyword>
	<keyword>lamotrigine</keyword>
	<keyword>child</keyword>
	<keyword>mania</keyword>
</DOC>